New horizons in breast cancer: the promise of immunotherapy-Reference-Cited by-同舟云学术

New horizons in breast cancer: the promise of immunotherapy

Published:2018-06-18 Issue:2 Volume:21 Page:117-125
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

de la Cruz-Merino L.^ORCID, ,Palazón-Carrión N.,Henao-Carrasco F.,Nogales-Fernández E.,Álamo-de la Gala M.,Vallejo-Benítez A.,Chiesa M.,Sánchez-Margalet V.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s12094-018-1907-3/fulltext.html

Reference42 articles.

1. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–70. https://doi.org/10.1126/science.1203486 .

2. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Investig. 2007;117(5):1137–46. https://doi.org/10.1172/jci31405 .

3. Bohling SD, Allison KH. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod Pathol. 2008;21(12):1527–32. https://doi.org/10.1038/modpathol.2008.160 .

4. Savas P, Salgado R, Denkert C, Sotiriou C, Darcy PK, Smyth MJ, et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol. 2016;13(4):228–41. https://doi.org/10.1038/nrclinonc.2015.215 .

5. Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs working group 2014. Ann Oncol. 2015;26(2):259–71. https://doi.org/10.1093/annonc/mdu450 .

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Feature-Based Classification of Retroperitoneal Liposarcoma: A Prospective Cohort Study;2024-08-09

2. Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types;Cancers;2024-04-23

3. FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer;Breast Cancer Research and Treatment;2023-07-17

4. FN1 Mediated Activation of Aspartate Metabolism Promotes the Progression of Triple-negative and Luminal A Breast Cancer;2023-05-08

5. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells;International Journal of Molecular Sciences;2023-03-08